Evaluation of itch and pain induced by bovine adrenal medulla (BAM)8–22, a new human model of non-histaminergic itch

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Evaluation of itch and pain induced by bovine adrenal medulla (BAM)8–22, a new human model of non-histaminergic itch. / Aliotta, Giulia Erica; Lo Vecchio, Silvia; Elberling, Jesper; Arendt-Nielsen, Lars.

I: Experimental Dermatology, Bind 31, Nr. 9, 2022, s. 1402-1410.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Aliotta, GE, Lo Vecchio, S, Elberling, J & Arendt-Nielsen, L 2022, 'Evaluation of itch and pain induced by bovine adrenal medulla (BAM)8–22, a new human model of non-histaminergic itch', Experimental Dermatology, bind 31, nr. 9, s. 1402-1410. https://doi.org/10.1111/exd.14611

APA

Aliotta, G. E., Lo Vecchio, S., Elberling, J., & Arendt-Nielsen, L. (2022). Evaluation of itch and pain induced by bovine adrenal medulla (BAM)8–22, a new human model of non-histaminergic itch. Experimental Dermatology, 31(9), 1402-1410. https://doi.org/10.1111/exd.14611

Vancouver

Aliotta GE, Lo Vecchio S, Elberling J, Arendt-Nielsen L. Evaluation of itch and pain induced by bovine adrenal medulla (BAM)8–22, a new human model of non-histaminergic itch. Experimental Dermatology. 2022;31(9):1402-1410. https://doi.org/10.1111/exd.14611

Author

Aliotta, Giulia Erica ; Lo Vecchio, Silvia ; Elberling, Jesper ; Arendt-Nielsen, Lars. / Evaluation of itch and pain induced by bovine adrenal medulla (BAM)8–22, a new human model of non-histaminergic itch. I: Experimental Dermatology. 2022 ; Bind 31, Nr. 9. s. 1402-1410.

Bibtex

@article{6da8f69a6fc045fd935e519ba1943e40,
title = "Evaluation of itch and pain induced by bovine adrenal medulla (BAM)8–22, a new human model of non-histaminergic itch",
abstract = "Chronic itch is a socioeconomic burden with limited management options. Non-histaminergic itch, involved in problematic pathological itch conditions, is transmitted by a subgroup of polymodal C-fibres. Cowhage is traditionally used for studying experimentally induced non-histaminergic itch in humans but encounters some limitations. The present study, therefore, aims to design a new human, experimental model of non-histaminergic itch based on the application of bovine adrenal medulla (BAM)8–22, an endogenous peptide that activates the MrgprX1 receptor. Twenty-two healthy subjects were recruited. Different concentrations (0.5, 1 and 2 mg/ml) of BAM8-22 solution and vehicle, applied by a single skin prick test (SPT), were tested in the first session. In the second session, the BAM8-22 solution (1 mg/ml) was applied by different number of SPTs (1, 5 and 25) and by heat-inactivated cowhage spicules coated with BAM8-22. Provoked itch and pain intensities were monitored for 9 min, followed by the measurement of superficial blood perfusion (SBP) and mechanical and thermal sensitivities. BAM8-22 induced itch at the concentration of 1, 2 mg/ml (p < 0.05) and with the significantly highest intensity when applied through BAM8-22 spicules (p < 0.001). No concomitant pain sensation or increased SBP was observed. SBP increased only in the 25 SPTs area probably due to microtrauma from the multiple skin penetrations. Mechanical and thermal sensitivities were not affected by any of the applications. BAM8-22 applied through heat-inactivated spicules was the most efficient method to induce itch (without pain or changes in SBP and mechanical and thermal sensitivities) suggesting BAM8-22 as a novel non-histaminergic, human, experimental itch model.",
keywords = "BAM8-22, cowhage spicules, itch, non-histaminergic itch, pain",
author = "Aliotta, {Giulia Erica} and {Lo Vecchio}, Silvia and Jesper Elberling and Lars Arendt-Nielsen",
note = "Publisher Copyright: {\textcopyright} 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.",
year = "2022",
doi = "10.1111/exd.14611",
language = "English",
volume = "31",
pages = "1402--1410",
journal = "Experimental Dermatology",
issn = "0906-6705",
publisher = "Wiley-Blackwell",
number = "9",

}

RIS

TY - JOUR

T1 - Evaluation of itch and pain induced by bovine adrenal medulla (BAM)8–22, a new human model of non-histaminergic itch

AU - Aliotta, Giulia Erica

AU - Lo Vecchio, Silvia

AU - Elberling, Jesper

AU - Arendt-Nielsen, Lars

N1 - Publisher Copyright: © 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

PY - 2022

Y1 - 2022

N2 - Chronic itch is a socioeconomic burden with limited management options. Non-histaminergic itch, involved in problematic pathological itch conditions, is transmitted by a subgroup of polymodal C-fibres. Cowhage is traditionally used for studying experimentally induced non-histaminergic itch in humans but encounters some limitations. The present study, therefore, aims to design a new human, experimental model of non-histaminergic itch based on the application of bovine adrenal medulla (BAM)8–22, an endogenous peptide that activates the MrgprX1 receptor. Twenty-two healthy subjects were recruited. Different concentrations (0.5, 1 and 2 mg/ml) of BAM8-22 solution and vehicle, applied by a single skin prick test (SPT), were tested in the first session. In the second session, the BAM8-22 solution (1 mg/ml) was applied by different number of SPTs (1, 5 and 25) and by heat-inactivated cowhage spicules coated with BAM8-22. Provoked itch and pain intensities were monitored for 9 min, followed by the measurement of superficial blood perfusion (SBP) and mechanical and thermal sensitivities. BAM8-22 induced itch at the concentration of 1, 2 mg/ml (p < 0.05) and with the significantly highest intensity when applied through BAM8-22 spicules (p < 0.001). No concomitant pain sensation or increased SBP was observed. SBP increased only in the 25 SPTs area probably due to microtrauma from the multiple skin penetrations. Mechanical and thermal sensitivities were not affected by any of the applications. BAM8-22 applied through heat-inactivated spicules was the most efficient method to induce itch (without pain or changes in SBP and mechanical and thermal sensitivities) suggesting BAM8-22 as a novel non-histaminergic, human, experimental itch model.

AB - Chronic itch is a socioeconomic burden with limited management options. Non-histaminergic itch, involved in problematic pathological itch conditions, is transmitted by a subgroup of polymodal C-fibres. Cowhage is traditionally used for studying experimentally induced non-histaminergic itch in humans but encounters some limitations. The present study, therefore, aims to design a new human, experimental model of non-histaminergic itch based on the application of bovine adrenal medulla (BAM)8–22, an endogenous peptide that activates the MrgprX1 receptor. Twenty-two healthy subjects were recruited. Different concentrations (0.5, 1 and 2 mg/ml) of BAM8-22 solution and vehicle, applied by a single skin prick test (SPT), were tested in the first session. In the second session, the BAM8-22 solution (1 mg/ml) was applied by different number of SPTs (1, 5 and 25) and by heat-inactivated cowhage spicules coated with BAM8-22. Provoked itch and pain intensities were monitored for 9 min, followed by the measurement of superficial blood perfusion (SBP) and mechanical and thermal sensitivities. BAM8-22 induced itch at the concentration of 1, 2 mg/ml (p < 0.05) and with the significantly highest intensity when applied through BAM8-22 spicules (p < 0.001). No concomitant pain sensation or increased SBP was observed. SBP increased only in the 25 SPTs area probably due to microtrauma from the multiple skin penetrations. Mechanical and thermal sensitivities were not affected by any of the applications. BAM8-22 applied through heat-inactivated spicules was the most efficient method to induce itch (without pain or changes in SBP and mechanical and thermal sensitivities) suggesting BAM8-22 as a novel non-histaminergic, human, experimental itch model.

KW - BAM8-22

KW - cowhage spicules

KW - itch

KW - non-histaminergic itch

KW - pain

U2 - 10.1111/exd.14611

DO - 10.1111/exd.14611

M3 - Journal article

C2 - 35587729

AN - SCOPUS:85131080472

VL - 31

SP - 1402

EP - 1410

JO - Experimental Dermatology

JF - Experimental Dermatology

SN - 0906-6705

IS - 9

ER -

ID: 320657778